Literature DB >> 17065297

Major depressive disorder: similar remission rates with bupropion, sertraline, or venlafaxine following treatment switch from citalopram.

George I Papakostas1.   

Abstract

Entities:  

Year:  2006        PMID： 17065297     DOI： 10.1136/ebmh.9.4.100

Source DB:  PubMed          Journal:  Evid Based Ment Health        ISSN： 1362-0347


× No keyword cloud information.
  1 in total

Review 1.  Bupropion: a review of its use in the management of major depressive disorder.

Authors:  Sohita Dhillon; Lily P H Yang; Monique P Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.